Ninad Khandekar
Role not yet determined Is this you? Add your title
Also affiliated: University of Southern California (2024); Government Medical College (2020); Government Medical College and Hospital (2024); Rochester General Hospital (2026)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Ninad Khandekar's research focuses on cardiovascular and renal conditions, particularly in the context of heart failure and chronic kidney disease. He has investigated the interplay between these conditions, exploring aspects of cardiorenal syndrome and its impact on patients with preserved ejection fraction. His work also examines specific patient populations, such as those with atrial fibrillation undergoing dialysis, and explores treatment options like left atrial appendage occlusion versus anticoagulants. Additionally, Khandekar has studied the use of GLP-1 agonists in non-dialysis chronic kidney disease patients concerning atrial fibrillation risk and has contributed to research on sepsis-related outcomes in patients with chronic kidney disease, including the use of hydrocortisone for septic shock. His scholarly output includes 15 publications with an h-index of 3 and 34 citations. He collaborates with several researchers at the University of Arkansas for Medical Sciences, including Nishank Jain, Craig Porter, Yasir Rahmatallah, and Rupak Pathak.
Metrics
- h-index: 3
- Publications: 16
- Citations: 35
Selected Publications
-
26-A-10911-ACC EFFECT OF GLUCAGON-LIKE RECEPTOR PEPTIDE-1 AGONISTS ON ATRIAL FIBRILLATION-RELATED EVENTS AND INCIDENCE IN CHRONIC KIDNEY DISEASE (2026)
-
Sepsis-Related Hospitalization and Mortality in Patients with CKD (2025)
-
Left Atrial Appendage Occlusion vs Anticoagulants in Dialysis With Atrial Fibrillation (2025)
Collaboration Network
Top Collaborators
- Left Atrial Appendage Occlusion vs Anticoagulants in Dialysis With Atrial Fibrillation
- Sepsis-Related Hospitalization and Mortality in Patients with CKD
- 26-A-10911-ACC EFFECT OF GLUCAGON-LIKE RECEPTOR PEPTIDE-1 AGONISTS ON ATRIAL FIBRILLATION-RELATED EVENTS AND INCIDENCE IN CHRONIC KIDNEY DISEASE
- Left Atrial Appendage Occlusion vs Anticoagulants in Dialysis With Atrial Fibrillation
- Left Atrial Appendage Occlusion vs Anticoagulants in Dialysis With Atrial Fibrillation
- Left Atrial Appendage Occlusion vs Anticoagulants in Dialysis With Atrial Fibrillation
- Left Atrial Appendage Occlusion vs Anticoagulants in Dialysis With Atrial Fibrillation
- Left Atrial Appendage Occlusion vs Anticoagulants in Dialysis With Atrial Fibrillation
- Left Atrial Appendage Occlusion vs Anticoagulants in Dialysis With Atrial Fibrillation
- Left Atrial Appendage Occlusion vs Anticoagulants in Dialysis With Atrial Fibrillation
- Left Atrial Appendage Occlusion vs Anticoagulants in Dialysis With Atrial Fibrillation
- Left Atrial Appendage Occlusion vs Anticoagulants in Dialysis With Atrial Fibrillation
- Left Atrial Appendage Occlusion vs Anticoagulants in Dialysis With Atrial Fibrillation
- Sepsis-Related Hospitalization and Mortality in Patients with CKD
- Sepsis-Related Hospitalization and Mortality in Patients with CKD
- Sepsis-Related Hospitalization and Mortality in Patients with CKD
- 26-A-10911-ACC EFFECT OF GLUCAGON-LIKE RECEPTOR PEPTIDE-1 AGONISTS ON ATRIAL FIBRILLATION-RELATED EVENTS AND INCIDENCE IN CHRONIC KIDNEY DISEASE
Similar Researchers
Based on overlapping research topics